Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IoM Drug Safety Review Should Reach Beyond FDA, Agency’s Woodcock Says

Executive Summary

The scope of the Institute of Medicine's assessment of the U.S. drug safety system must extend beyond an evaluation of FDA's capabilities, FDA Acting Deputy Commissioner for Operations Janet Woodcock said June 8

You may also be interested in...



Pharma Spends 0.3% Of Sales On Post-Market Safety Activities, CERT Says

Pharmaceutical companies spend an average 0.3% of sales on post-marketing safety studies, an unpublished Centers for Education & Research on Therapeutics report finds

Pharma Spends 0.3% Of Sales On Post-Market Safety Activities, CERT Says

Pharmaceutical companies spend an average 0.3% of sales on post-marketing safety studies, an unpublished Centers for Education & Research on Therapeutics report finds

WLF Questions Ad Division Allegations; “DDMAC Watch” Starts With Strattera

Direct-to-consumer advertising does not endanger the public health because access to prescription drugs is controlled by physicians, not the public, the Washington Legal Foundation's new advertising regulation watchdog group suggests

Related Content

Topics

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel